MoneyWorks4Me

The revenue declined to Rs. 105.81 millions for the quarter ended June 2023 as compared to Rs. 106.41 millions during the corresponding quarter last year.The Net Loss for the quarter ended June 2023 is Rs. -53.32 millions as compared to Net Loss of Rs. -81.36 millions of corresponding quarter ended June 2022 Operating profit Margin for the quarter ended June 2023 improved to -25.82% as compared to -61.39% of corresponding quarter ended June 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 105.81 106.41 -0.56 105.81 106.41 -0.56 521.34 597.03 -12.68
Other Income 0.38 1.29 -70.54 0.38 1.29 -70.54 6.20 11.56 -46.37
PBIDT -25.82 -61.39 -57.94 -25.82 -61.39 -57.94 -151.59 -328.39 -53.84
Interest 10.97 3.04 260.86 10.97 3.04 260.86 29.73 53.91 -44.85
PBDT -36.79 -64.43 -42.90 -36.79 -64.43 -42.90 -181.32 -382.30 -52.57
Depreciation 16.53 16.93 -2.36 16.53 16.93 -2.36 65.59 62.97 4.16
PBT -53.32 -81.36 -34.46 -53.32 -81.36 -34.46 -246.91 -445.27 -44.55
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -53.32 -81.36 -34.46 -53.32 -81.36 -34.46 -246.91 -445.27 -44.55
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) -24.40 -57.69 -57.70 -24.40 -57.69 -57.70 -29.08 -55.00 -47.14
Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..